Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.
Molecular Weight:
206.63
Purity:
99.81%
CAS Number:
[16142-27-1]
Formula:
C6H11ClN4O2
Target:
Drug Metabolite|||NF-kappaB|||Apoptosis|||Annexin A|||Autophagy|||ROS
T23356
* VAT and and shipping costs not included. Errors and price changes excepted
